FACIAL ANGIOFIBROMAS IN TUBEROUS SCLEROSIS COMPLEX Recognition, Treatment and Case-Based Management

November 17, 2026

Facial angiofibroma is a common and distinctive manifestation of tuberous sclerosis complex (TSC). Recognizing these lesions is important because, in some patients, they may be an early clue to previously undiagnosed TSC. For patients with an
established diagnosis, however, questions about how and when to treat facial angiofibroma can be complex. This program will provide practical guidance on treatment options and management considerations through expert discussion and case-based examples.

Target Audience

This activity is designed for an audience of Dermatologists, Neurologists, Dermatology Nurses, Physician Assistants, Pediatric Physicians, Pharmacists, Pharmacy technicians and other healthcare professionals.

Learning Objectives

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Recognizing facial angiofibromas and their clinical presentation
  • Understanding factors that influence treatment decisions

Course summary

Available credit: 
  • 1.00 AANP Contact Hours

    Nurse Practitioners
    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Kikaku America International.  AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 0.50 hour(s) of pharmacology).

    • 0.50 AANP Pharmacology Contact Hours
  • 1.00 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.00 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.

  • 1.00 ACPE Pharmacy Technician

    Pharmacy Technicians
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.

  • 1.00 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC Contact Hours

    Nurses
    Credit being awarded: 1.00 ANCC contact hours

  • 1.00 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.

Course opens: 
11/17/2026
Course expires: 
01/17/2027
Event starts: 
11/17/2026 - 8:00pm EST
Event ends: 
11/17/2026 - 9:15pm EST
Cost:
$0.00
Add to calendar: 
Rating: 
0

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Dawn Eichenfield, MD, PhD

has a financial relationship (Researcher) with Johnson and Johnson;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Consultant) with Chiesi;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Consultant) with Eli Lilly and Company;.
has a financial relationship (Researcher) with Eli Lilly and Company;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Researcher) with Incyte;.
has a financial relationship (Consultant) with Nobelpharma;.
has a financial relationship (Consultant) with Ortho Dermatologics;.
has a financial relationship (Consultant) with Palvella;.
has a financial relationship (Consultant) with Pelthos;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Sanofi;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Consultant) with Verrica;.
has a financial relationship (Speaker) with Verrica;.

Bernadette Makar, MSN, APRN-BC, NP-C

has no relevant financial relationships to disclose at this time.

Deeti Pithadia, MD

has no relevant financial relationships to disclose at this time.

Peter Sonnenreich

has no relevant financial relationships to disclose at this time.
Author, Writer(s)

Dawn Eichenfield, MD, PhD

has a financial relationship (Speaker) with Verrica;.
has a financial relationship (Consultant) with Verrica;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Consultant) with Chiesi;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Consultant) with Eli Lilly and Company;.
has a financial relationship (Researcher) with Eli Lilly and Company;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Researcher) with Incyte;.
has a financial relationship (Researcher) with Johnson and Johnson;.
has a financial relationship (Consultant) with Nobelpharma;.
has a financial relationship (Consultant) with Ortho Dermatologics;.
has a financial relationship (Consultant) with Palvella;.
has a financial relationship (Consultant) with Pelthos;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Sanofi;.

Deeti Pithadia, MD

has no relevant financial relationships to disclose at this time.
Course Director(s)

Dawn Eichenfield, MD, PhD

has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Speaker) with Verrica;.
has a financial relationship (Consultant) with Verrica;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Consultant) with Sanofi;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Pelthos;.
has a financial relationship (Consultant) with Palvella;.
has a financial relationship (Consultant) with Ortho Dermatologics;.
has a financial relationship (Consultant) with Nobelpharma;.
has a financial relationship (Researcher) with Incyte;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Researcher) with Eli Lilly and Company;.
has a financial relationship (Consultant) with Eli Lilly and Company;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Researcher) with Johnson and Johnson;.
has a financial relationship (Consultant) with Chiesi;.

Deeti Pithadia, MD

has no relevant financial relationships to disclose at this time.
Moderator(s)

Joyce Teng, MD PhD

has no relevant financial relationships to disclose at this time.
Reviewer(s)

Bernadette Makar, MSN, APRN-BC, NP-C

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Dawn Eichenfield, MD, PhD

has a financial relationship (Consultant) with Pelthos;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Consultant) with Chiesi;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Speaker) with Verrica;.
has a financial relationship (Consultant) with Verrica;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Consultant) with Sanofi;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Eli Lilly and Company;.
has a financial relationship (Consultant) with Palvella;.
has a financial relationship (Consultant) with Ortho Dermatologics;.
has a financial relationship (Consultant) with Nobelpharma;.
has a financial relationship (Researcher) with Johnson and Johnson;.
has a financial relationship (Researcher) with Incyte;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Researcher) with Eli Lilly and Company;.

Deeti Pithadia, MD

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Kikaku America International. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Available Credit

  • 1.00 AANP Contact Hours

    Nurse Practitioners
    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Kikaku America International.  AKH Inc., Advancing Knowledge in Healthcare is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 0.50 hour(s) of pharmacology).

    • 0.50 AANP Pharmacology Contact Hours
  • 1.00 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.00 ACPE Pharmacist

    Pharmacists
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.

  • 1.00 ACPE Pharmacy Technician

    Pharmacy Technicians
    AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.00 contact hours.

  • 1.00 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 ANCC Contact Hours

    Nurses
    Credit being awarded: 1.00 ANCC contact hours

  • 1.00 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.

Price

Cost:
$0.00
Please login or register to take this course.

Criteria for Success
To obtain credit, you must complete the activity evaluation and claim credit based on your attendance.  The Certificate of Completion is immediately available for download after submitting your evaluation.  It will remain in your profile transcript for future retrieval if needed.  It can be found under My Account > My Activities > Completed Activities.

If you have any questions, contact [email protected].